Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugAntibioticFirst approved 1982

Targadox(Doxycycline Hyclate)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$7,691

Medicare cost, 2024

Medicare drug plans spent $7,691 on Targadox (doxycycline hyclate) in 2024, for 14 prescriptions and refills. Spending fell 72% from 2023 to 2024.

Medicare cost, 2024

$7,691

-72.2% from 2023

Prescriptions

14

$549.38 per claim

Patients

-

2 prescribers

Total spending, 2024

$7,691

- per patient

Questions and answers

How much does Medicare spend on Targadox?

Medicare prescription drug plans paid $7,691 for Targadox in 2024, for 14 prescriptions and refills to - patients (down 72.2% from 2023). The average cost per claim was $549.38.

Which state spends the most on Targadox?

Arizona had the highest Medicare cost for Targadox in 2024: $5,115 for 11 claims.

Who prescribes Targadox the most?

Matthew T Woods, dermatology in Gilbert, AZ, had the highest Medicare cost for Targadox in 2024: 11 claims costing $5,115.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Targadox was $7,691 in 2024, after a high of $86K in 2021.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Targadox, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Matthew T Woods Gilbert, AZDermatology11Under 11$5,115

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022308731$67K
2023204320$28K
2024214-$7,691

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Journey Medical14$7,691

Codes

National drug codes (packages)
2
RxNorm concept IDs
1652674, 1806948
Application numbers
ANDA062269

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube